News Releases

Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.

Month Year

Nov 16, 2017

Nearly 3,000 Women Across America Reveal Surprising Lengths and Locations They've Had to Go to Answer Nature's Urgent Call
Nov 15, 2017

Astellas Oncology Awards $100,000 in C3 Prize™ Grants to Five Innovators Working to Change Cancer Care

- Grand Prize winner Hernâni Oliveira of Porto, Portugal will receive a $50,000 grant from Astellas plus a one-year nights and weekends membership to MATTER, a healthcare innovation community -
- Photos 1
Nov 10, 2017

Astellas Named a Best Place to Work for Lesbian, Gay, Bisexual, and Transgender Equality for Fourth Consecutive Year
- Photos 1
Nov 8, 2017

Astellas and Seattle Genetics Initiate Phase 1b Trial of Enfortumab Vedotin in Combination with Immune Checkpoint Inhibitor Therapies in Locally Advanced or Metastatic Urothelial Cancer

ADC Combination Study Focuses on First-Line Treatment
Nov 1, 2017

Astellas Announces Leadership Changes in U.S. Health Systems Commercial Organization

James Miteff and Gregory Apostol promoted to key national leadership roles.
- Photos 2
Oct 31, 2017

Astellas Appoints Nate Crisel to Vice President, Real World Informatics & Analytics
- Photos 2
Oct 31, 2017

Astellas Reports First Half FY2017 Financial Results, Revises Fiscal Year Outlook
Oct 30, 2017

Astellas Appoints Gary Thal, M.D., to Vice President, Specialty, Medical Affairs, Americas
- Photos 1
Oct 24, 2017

Astellas Oncology Selects Five C3 Prize® Finalists to Pitch Ideas for Changing Cancer Care at the Union for International Cancer Control (UICC) World Cancer Leaders' Summit

In the challenge's second year, five entrants will compete for a chance to win a Grand Prize of $50,000 from Astellas and a consultation with Robert Herjavec, star of ABC's Emmy Award-winning hit television show, Shark Tank
Oct 19, 2017

Astellas and Universal Cells, Inc. Announce a Collaboration Utilizing Universal Donor Cell Technology
- Photos 1

Show per page

Statements

Careers

Stay Connected

Get only the email alerts you want.

Media Contacts

For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.

Our communications team will respond to verified media requests within 24-48 hours as appropriate.

If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.

Download Fact Sheet

Sustainability

Investors

Explore U.S. Products

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa

News Releases

You are now leaving XTANDI.com

You are now leaving newsroom.astellas.com.